CHDS faculty members Lisa Robinson’s and James Hammitt’s work on benefit-cost analysis in low- and middle-income countries indicates that there is a strong need for more research on the values placed on mortality and morbidity risk reductions by members of these populations. Better understanding of these preferences is likely to aid in policy implementation as well as in estimating the benefits of alternative interventions.
Ms. Robinson recently participated in a related advisory group discussion focused on implementing one such study as part of the Decade of Vaccine Economics (DOVE) project, hosted by the International Vaccine Access Center at the Johns Hopkins Bloomberg School of Public Health and funded by the Bill & Melinda Gates Foundation.
Learn more: Read about the Guidelines for Benefit-Cost Analysis grant here.
Related news: Analysis of Deregulation Policy
Related news: Hammitt and Robinson Work on Benefit-Cost Analysis Guidelines